O'Shaughnessy Asset Management’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
Other funds holding FOLD
PA
ACA
PAI
O'Shaughnessy Asset Management's FOLD Position: Q4 2024 in Review
O'Shaughnessy Asset Management sold out of Amicus Therapeutics (FOLD) in Q4 2024, closing a stake of 14,156 shares — an estimated $148K sold.
O'Shaughnessy Asset Management first reported a position in FOLD in Q2 2020 and held it in 17 quarters. The position peaked at $360K in Q4 2020. 290 funds tracked by Wall St. Rank hold FOLD as of Q4 2024.
- O'Shaughnessy Asset Management reported no remaining Amicus Therapeutics position as of Q4 2024 after selling out during the quarter.
- O'Shaughnessy Asset Management sold 14,156 Amicus Therapeutics shares in Q4 2024, an estimated $148K.
- O'Shaughnessy Asset Management first reported a position in Amicus Therapeutics in Q2 2020 and held it in 17 quarters.
- O'Shaughnessy Asset Management's Amicus Therapeutics position peaked at $360K in Q4 2020.
- 290 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q4 2024.
Based on O'Shaughnessy Asset Management's 13F filing for Q4 2024, filed 12 Feb 2025.